Zytiga Sucks Customer Reviews and Feedback
Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). I
Richard mentioned this heart breaking comment, "Started taking 1000mg of Zytiga almost 3 weeks ago but having difficulty with weakness and pain in legs; it got so bad I was unable to walk. I was also extremely tired, but not sure if that is from Zytiga or morphine I need to take also. My prostate cancer found in Feb 2011, Gleason score 9/10; prostate removed May 2011; radiation in 2014, then tumor found in 2018. Started Lupron in 2019. My PSA score was never above 4.0 even prior to surgery when it was in 75% of prostate and had spread outside my prostate in several places. Hoping to switch to another medication that has fewer side effects for me. I am only 65."
DM says"Great communication great service fast delivery. Product came unmarked with no label in a vacuum sealed bag. Oil had a very strong chemical smell that changed my sense of smell for 3 weeks and left a very painful injection site and made me sick. No telling what this stuff was. I would steer clear."
SteadyWINNING says"Scam, do not order go to AAS Pharm/acy instead"
Lasha Revia says"BEST SCAM ARTISTS EVER!!!"
SteadyWINNING says"Absolutely terrible! NEVER order from them. Will steal your money and ghost"
Neil Walker says"@ethansgrumps Think I might just pip you...? Monday: Bloods Tuesday: PSA, Bone and CT scan results plus oncologist… https://t.co/ygShy3QSnf"
Advanced Prostate Ca says"Is ADT Necessary When You Take Abiraterone Acetate (Zytiga)? https://t.co/INBkVc5e81"
CancerABCs says"Is ADT Necessary When You Take Abiraterone Acetate (Zytiga)? https://t.co/F6Phtoi1v2"
Prostate Cancer Joel says"Is ADT Necessary When You Take Abiraterone Acetate (Zytiga)? https://t.co/fJAVhMNNKs"
In The News
Prostate Cancer News Today reports"Adding Provenge to Xtandi, Zytiga Reduces Risk of Death by 45% in..."
Curetoday.com reports"In Prostate Cancer, Xtandi Sparks More Fatigue and Pain Than Zytiga"
Prostate Cancer News Today reports"Add-on onvansertib overcomes resistance to Zytiga in metastatic castration-resistant prostate cancer, Phase 2 study finds"
Business Wire reports"Real-World Study of 6000+ Medicare Patients with Advanced Prostate Cancer Shows Adding PROVENGE® (sipuleucel-T) to Treatment Regimen Reduced Risk of Death by 45%"